Mattias K Andersson
11PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Nov 12, 2025
Pan-cyclin-dependent kinase inhibition is a potential treatment for adenoid cystic carcinoma that downregulates the MYB::NFIB fusion and induces tumor regression.Junchi Huang, Peter Larsson, Maryam Kakay Afshari
|Feb 25, 2025
Alternative MYB Promoter Activity Is a Potential Prognostic Biomarker in Head and Neck Adenoid Cystic Carcinoma.Fredrik Jäwert, André Fehr, Marta Persson
|Jan 15, 2025
The Transcriptomic and Gene Fusion Landscape of Pleomorphic Salivary Gland Adenomas.Maryam Kakay Afshari, Paloma Tejera Nevado, André Fehr
|Dec 19, 2023
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma.Ylenia Cicirò, Denise Ragusa, Paloma Tejera Nevado
|Aug 11, 2023
Comprehensive molecular characterization of adenoid cystic carcinoma reveals tumor suppressors as novel drivers and prognostic biomarkers.Marta Persson, Mattias K Andersson, Per-Erik Sahlin
|May 23, 2023
Increased MYB alternative promoter usage is associated with relapse in acute lymphoblastic leukemia.André Fehr, Gustav Arvidsson, Jessica Nordlund
Pageof 2
Frequent Collaborators
6 joint publications
Göran Stenman
5 joint publications
André Fehr
2 joint publications
Yoshitsugu Mitani
1 joint publications
Carla Abrahamian
1 joint publications
Amanda Kedaigle
1 joint publications
Göran Stenman
1 joint publications
Cyrus Khandanpour
1 joint publications
Rainer Schobert
1 joint publications
Adel K El-Naggar
1 joint publications
Vincent Vander Poorten
